August 2017

Reducing overall antibiotic exposure is likely to have an impact on decreasing antimicrobial resistance.

As the influential management consultant and business visionary Peter Drucker once said, “The entrepreneur always searches for change, responds to it, and exploits it as an opportunity.”

Candida auris—Are we prepared for another multidrug-resistant pathogen?

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.

Although focused in the northeastern United States, Lyme disease has ex­panded geographically over the past few decades, with a >320% increase in the number of high-incidence counties and reported cases in 49 states.

Despite the progress that has been made, more research is needed on cancer prevention, hepatitis B, and human papillomavirus vaccines.

Parallels between the recent Zika epidemic in Brazil and the HIV pandemic in the 1980s, stress the importance of improving responses to public health crises.

With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.

Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.